Current advances in biomarkers for targeted therapy in triple-negative breast cancer
Abstract: Triple-negative breast cancer (TNBC) is a complex heterogeneous disease characterized by the absence of three hallmark receptors: human epidermal growth factor receptor 2, estrogen receptor, and progesterone receptor. Compared to other breast cancer subtypes, TNBC is more aggressive, has a...
Saved in:
Main Authors: | , , |
---|---|
格式: | Revisão |
语言: | 英语 |
出版: |
2016
|
在线阅读: | https://doi.org/10.2147/bctt.s114659 https://www.dovepress.com/getfile.php?fileID=32807 |
标签: |
添加标签
没有标签, 成为第一个标记此记录!
|